Anthranilamide

Name: Anthranilamide
Brand: SIAL
Price: 7375 MXP

suitable for matrix substance for MALDI-MS, ≥99.0% (HPLC)

Synonym(s):

2-AB, 2-Aminobenzamide, Anthranilic acid amide

Slide 1 of 1

Select a Size

1 G

MXP 7,375.00

Check Cart for Availability

Request a Bulk Order

About This Item

Linear Formula:

2-(H₂N)C₆H₄CONH₂

CAS Number:

88-68-6

Molecular Weight:

136.15

UNSPSC Code:

23151817

NACRES:

NA.21

PubChem Substance ID:

329767409

EC Number:

201-851-2

Beilstein/REAXYS Number:

508509

MDL number:

MFCD00007981

Key Documents

View All Documentation

Product Name

Anthranilamide, suitable for matrix substance for MALDI-MS, ≥99.0% (HPLC)

InChI

1S/C7H8N2O/c8-6-4-2-1-3-5(6)7(9)10/h1-4H,8H2,(H2,9,10)

InChI key

PXBFMLJZNCDSMP-UHFFFAOYSA-N

SMILES string

NC(=O)c1ccccc1N

assay

≥99% (NT)
≥99.0% (HPLC)

form

crystals

technique(s)

MALDI-MS: suitable

mp

111-113 °C (lit.)

cation traces

Ba: ≤5 mg/kg
Ca: ≤5 mg/kg
Cd: ≤5 mg/kg
Co: ≤5 mg/kg
Cr: ≤5 mg/kg
Cu: ≤5 mg/kg
Fe: ≤30 mg/kg
K: ≤50 mg/kg
Mg: ≤5 mg/kg
Mn: ≤5 mg/kg
Na: ≤150 mg/kg
Ni: ≤5 mg/kg
Pb: ≤5 mg/kg
Zn: ≤5 mg/kg

suitability

suitable for matrix substance for MALDI-MS

Quality Level

100

Looking for similar products? Visit Product Comparison Guide

Related Categories

Analytical Reagents

Chromatography & Spectroscopy Reagents

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item	A89804	A0884	92574
Supelco 76884 Anthranilamide	Sigma-Aldrich A89804 Anthranilamide	Sigma-Aldrich A0884 L-Asparagine	Supelco 92574 Mefenamic acid
assay ≥99% (NT), ≥99.0% (HPLC)	assay ≥98%	assay ≥98% (HPLC)	assay ≥98.5% (HPLC)
Quality Level 100	Quality Level -	Quality Level 300	Quality Level 100
form crystals	form crystals	form powder	form -
mp 111-113 °C (lit.)	mp 111-113 °C (lit.)	mp 235 °C (dec.) (lit.)	mp -
grade matrix substance for MALDI-MS	grade -	grade -	grade analytical standard
technique(s) MALDI-MS: suitable	technique(s) -	technique(s) -	technique(s) HPLC: suitable, gas chromatography (GC): suitable

Analysis Note

metal trace analysis (ICP) corresponds to requirements

Application

Used for non-selective, efficient fluorescent labeling of glycans. Slightly less sensitive than anthranilic acid (2-AA) for glycan labeling.

related product

Product No.

Description

Pricing

P2613

ProteoMass^™ P₁₄R MALDI-MS Standard, vial of 10 nmol

C8857

ProteoMass^™ Cytochrome c MALDI-MS Standard, vial of 10 nmol, (M+H⁺) 12,361.96 Da by calculation

C8982

α-Cyano-4-hydroxycinnamic acid, suitable for MALDI-TOF MS

A8346

ProteoMass^™ ACTH Fragment 18-39 MALDI-MS Standard, vial of 10 nmol, monoisotopic mol wt 2,464.1989 Da

I6154

ProteoMass^™ Insulin chain B oxidized MALDI-MS Standard, vial of 10 nmol

I6279

ProteoMass^™ Insulin MALDI-MS Standard, vial of 10 nmol, monoisotopic mol wt 5,729.6087 Da

A8471

ProteoMass^™ Albumin MALDI-MS Standard, vial of 10 nmol, average mol wt 66,429.09 Da by calculation

A9096

ProteoMass^™ Aldolase MALDI-MS Standard, vial of 10 nmol, average mol wt 39,211.28 Da by calculation

A8846

ProteoMass^™ Angiotensin II MALDI-MS Standard, vial of 10 nmol

A8971

ProteoMass^™ Apomyoglobin MALDI-MS Standard, vial of 10 nmol, (M+H⁺) 16,952.27 Da by calculation

B4181

ProteoMass^™ Bradykinin Fragment 1-7 MALDI-MS Standard, vial of 10 nmol, monoisotopic mol wt 756.3997 Da

MSCAL1

ProteoMass^™ Peptide and Protein MALDI-MS Calibration Kit, Peptide and Protein MALDI MS Calibration Standard

MSCAL2

ProteoMass^™ Peptide MALDI-MS Calibration Kit, Peptide MALDI MS Calibration Standard

MSCAL3

ProteoMass^™ Protein MALDI-MS Calibration Kit, Protein MALDI MS Calibration Standard

56197

3-Hydroxypicolinic acid, suitable for matrix substance for MALDI-MS, ≥99.0% (HPLC)

54793

2-(4-Hydroxyphenylazo)benzoic acid, suitable for matrix substance for MALDI-MS, ≥99.5%

85429

Sinapic acid, suitable for matrix substance for MALDI-MS, ≥99.0% (T)

03565

MALDI validation set polystyrene Mp ~700 - 70 000, certified reference material

37468

2′,6′-Dihydroxyacetophenone, suitable for matrix substance for MALDI-MS, ≥99.5%

91928

2′,4′,6′-Trihydroxyacetophenone monohydrate, suitable for matrix substance for MALDI-MS, ≥99.5%

03597

MALDI validation set PS, PMMA, PDMS, PEG and PSS Mp ~4′300 - 6′500

87884

trans-2-[3-(4-tert-Butylphenyl)-2-methyl-2-propenylidene]malononitrile, suitable for matrix substance for MALDI-MS, ≥99.0% (HPLC)

60018

Caffeic acid, suitable for matrix substance for MALDI-MS, ≥99.0% (HPLC)

29208

(N-Succinimidyloxycarbonylmethyl)tris(2,4,6-trimethoxyphenyl)phosphonium bromide, for protein sequence analysis (by MALDI-MS), 98%

46278

trans-Ferulic acid, suitable for matrix substance for MALDI-MS, ≥99.0% (HPLC)

85707

2,5-Dihydroxybenzoic acid, suitable for matrix substance for MALDI-MS, >99.0% (HPLC)

70990

α-Cyano-4-hydroxycinnamic acid, suitable for matrix substance for MALDI-MS, ≥99.0% (HPLC)

N3786

α(2→3,6,8,9) Neuraminidase from Arthrobacter ureafaciens, Proteomics Grade, suitable for MALDI-TOF MS

39468

α-Cyano-4-hydroxycinnamic acid, suitable for matrix substance for MALDI-MS, Ultra pure

39319

2,5-Dihydroxybenzoic acid, suitable for matrix substance for MALDI-MS, ≥99.5% (HPLC), Ultra pure

49508

Sinapic acid, suitable for matrix substance for MALDI-MS, ≥99.5%, Ultra pure

50862

Super-DHB, suitable for matrix substance for MALDI-MS, ≥99.0%

02241

2′,3′-Dideoxycytidine 5′-triphosphate sodium salt solution, suitable for MALDI-MS, ≥98.0% (HPLC)

42597

3′-Deoxythymidine 5′-triphosphate sodium salt solution, BioChemika, puriss. p.a., suitable for MALDI-MS, ≥98.0% (HPLC)

MS0100

ProteoMass^™ Guanidination Kit, For improving MALDI-MS sensitivity and peptide sequence coverage

MSCAL4

ProteoMass^™ MALDI Calibration Kit for Exactive Series MS, LTQ XL and LTQ Hybrids, MALDI MS Calibration Standard

92817

9-Aminoacridine, suitable for matrix substance for MALDI-MS, ≥99.5% (HPLC)

56451

1,5-Diaminonaphthalene, suitable for matrix substance for MALDI-MS, ≥99.0% (HPLC)

50757

Micro-Array for Mass Spectrometry (MAMS), for single cell analysis

94141

4-Chloro-α-cyanocinnamic acid, suitable for matrix substance for MALDI-MS, ≥95.0% (HPLC)

89063

4-Bromo-α-cyanocinnamic acid, suitable for matrix substance for MALDI-MS, ≥95.0% (HPLC)

77081

α-Cyano-4-fluorocinnamic acid, suitable for matrix substance for MALDI-MS, ≥95.0% (HPLC)

38419

α-Cyano-2,3,4,5,6-pentafluorocinnamic acid, suitable for matrix substance for MALDI-MS, ≥95.0% (HPLC)

39379

4-Chloro-α-cyanocinnamic acid - α-Cyano-2,4-difluorocinnamic acid mixture, suitable for matrix substance for MALDI-MS, ≥95.0% (sum of both components, HPLC)

68914

4-Bromo-α-cyanocinnamic acid - 4-Chloro-α-cyanocinnamic acid mixture, suitable for matrix substance for MALDI-MS, ≥95.0% (sum of both components, HPLC)

78246

Curcumin, suitable for matrix substance for MALDI-MS, ≥99.5% (HPLC)

04973

Micro-Array for Mass Spectrometry (MAMS), for quantitative MALDI

94477

(E)-2-Cyano-3-(2-naphthyl)acrylic acid, suitable for matrix substance for MALDI-MS, ≥98.0% (HPLC)

83788

(2E)-3-(9-Anthryl)-2-cyanoacrylic acid, suitable for matrix substance for MALDI-MS, ≥97.0% (HPLC)

56229

9-Nitroanthracene, suitable for matrix substance for MALDI-MS, ≥98.5% (HPLC)

PFS11

SpheriCal^™ Mix, Peptide Low, suitable for MALDI-MS

PFS31

SpheriCal^™ Aqua, Peptide Medium, suitable for MALDI-MS

PFS32

SpheriCal^™ Aqua, Peptide High, suitable for MALDI-MS

PFS20

SpheriCal^™ Neat, Peptide Low, suitable for MALDI-MS

PFS21

SpheriCal^™ Neat, Peptide Medium, suitable for MALDI-MS

PFS22

SpheriCal^™ Neat, Peptide High, suitable for MALDI-MS

PFS23

SpheriCal^™ Neat, Protein Low, suitable for MALDI-MS

PFS30

SpheriCal^™ Aqua, Peptide Low, suitable for MALDI-MS

69028

4-Phenyl-α-cyanocinnamamide, suitable for matrix substance for MALDI-MS, ≥98.5% (HPLC)

900666

Bruker standard solvent, suitable for MALDI-MS, 50% ACN + 47.5% H₂O + 2.5% TFA

pictograms

GHS07

signalword

Warning

hcodes

H319

pcodes

P264 - P280 - P305 + P351 + P338 - P337 + P313

Hazard Classifications

Eye Irrit. 2

Storage Class

11 - Combustible Solids

wgk

WGK 1

flash_point_f

>365.0 °F

flash_point_c

> 185 °C

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

BCCD5145

BCBW6851

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Improved analysis of oligosaccharides for matrix-assisted laser desorption/ionization time-of-flight mass spectrometry using aminopyrazine as a derivatization reagent and a co-matrix.

Yan Cai et al.

The Analyst, 138(21), 6270-6276 (2013-09-07)

Analysis of oligosaccharides by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) is often limited by their low ionization efficiency and inadequate fragmentation information. Derivatizations of oligosaccharides to enhance their ionization in MS are widely used, but most of these

Target-directed development and preclinical characterization of the proposed biosimilar rituximab GP2013.

Antonio da Silva et al.

Leukemia & lymphoma, 55(7), 1609-1617 (2013-09-13)

Biosimilar development involves a target-directed iterative process to ensure a similar product to the originator. Here we report the preclinical development of the proposed biosimilar rituximab (GP2013). Post-translational modifications and bioactivities of GP2013 versus originator rituximab were engineered and monitored

Changes to serum sample tube and processing methodology does not cause Intra-Individual [corrected] variation in automated whole serum N-glycan profiling in health and disease.

Nicholas T Ventham et al.

PloS one, 10(4), e0123028-e0123028 (2015-04-02)

Serum N-glycans have been identified as putative biomarkers for numerous diseases. The impact of different serum sample tubes and processing methods on N-glycan analysis has received relatively little attention. This study aimed to determine the effect of different sample tubes

Identification of potential pancreatic cancer serum markers: Increased sialyl-Lewis X on ceruloplasmin.

Meritxell Balmaña et al.

Clinica chimica acta; international journal of clinical chemistry, 442, 56-62 (2015-01-18)

Pancreatic adenocarcinoma (PDAC) usually shows an enhanced expression of sialyl-Lewis X (sLe(x)) and related epitopes. PDAC may secrete some of the proteins carrying such increased sLe(x) determinant into serum, so they could be used as PDAC markers. Previously, we identified

Versatile characterization of glycosylation modification in CTLA4-Ig fusion proteins by liquid chromatography-mass spectrometry.

Lei Zhu et al.

mAbs, 6(6), 1474-1485 (2014-12-09)

CTLA4-Ig is a highly glycosylated therapeutic fusion protein that contains multiple N- and O-glycosylation sites. Glycosylation plays a vital role in protein solubility, stability, serum half-life, activity, and immunogenicity. For a CTLA4-Ig biosimilar development program, comparative analytical data, especially the

View All Related Papers

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service